Literature DB >> 22162736

A case of vitiligo vulgaris showing a pronounced improvement after treatment for myasthenia gravis.

Kiyotaka Nakamagoe1, Jun-Ichi Furuta, Ayako Shioya, Akira Tamaoka.   

Abstract

This is a report of a 64 year-old male patient whose myasthenia gravis (MG) was accompanied by vitiligo vulgaris. Depigmentation of the face, trunk, and hands was noted. He was diagnosed with vitiligo vulgaris according to macroscopic findings and a skin biopsy. He was also found to have blepharoptosis, and proximal dominant muscle weakness of the extremities. He was anti-acetylcholine receptor antibody-positive, with repetitive nerve stimulation showing a waning phenomenon and chest computed tomography showing invasive thymoma, which led to the diagnosis of generalised MG. His myasthenic symptoms were relieved by the use of steroids and the removal of the thymoma. His vitiligo vulgaris began to improve a month after the relief of myasthenic symptoms. Such improvement was pronounced during the next several months. The clinical or immunological relationship between MG and vitiligo vulgaris is still not known, but these findings might indicate clinical correlation between MG and vitiligo vulgaris.

Entities:  

Year:  2009        PMID: 22162736      PMCID: PMC3029627          DOI: 10.1136/bcr.07.2009.2091

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.

Authors:  Amrinder Jit Kanwar; Sunil Dogra; Davinder Parsad; Bhushan Kumar
Journal:  Int J Dermatol       Date:  2005-01       Impact factor: 2.736

2.  Narrow-band UVB treatment of vitiligo in Chinese.

Authors:  Guan-Yu Chen; M Ming-Long Hsu; Han-Kuo Tai; Tzu-Chieh Chou; Ching-Liang Tseng; Ho-Yuan Chang; Cheng-Che Eric Lan; Hamm-Ming Sheu
Journal:  J Dermatol       Date:  2005-10       Impact factor: 4.005

3.  Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.

Authors:  Electra Nicolaidou; Christina Antoniou; Alexander J Stratigos; Christina Stefanaki; Andreas D Katsambas
Journal:  J Am Acad Dermatol       Date:  2007-02       Impact factor: 11.527

4.  Vitiligo and Myasthenia Gravis.

Authors:  V N Sehgal; V L Rege; S N Desai
Journal:  Indian J Dermatol Venereol Leprol       Date:  1976 Jan-Feb       Impact factor: 2.545

5.  Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo.

Authors:  R S Tan
Journal:  Proc R Soc Med       Date:  1974-03

6.  Myasthenia gravis, rheumatoid arthritis, vitiligo, and autoimmune haemolytic anaemia.

Authors:  R A Durance; E B Hamilton
Journal:  Proc R Soc Med       Date:  1971-01

7.  Recurrence of thymoma with appearance of myasthenia gravis 18 years after surgery: a case report.

Authors:  T Shinkai; N Saijo; S Yoshioka; K Suemasu; H Hasegawa; N Miyazawa; T Kamiya; F Kanzawa; T Nakajima; Y Shimosato
Journal:  Jpn J Clin Oncol       Date:  1985-09       Impact factor: 3.019

8.  Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.

Authors:  Rajatanavin Natta; Tanratanakorn Somsak; Taechotirote Wisuttida; Limtakul Laor
Journal:  J Am Acad Dermatol       Date:  2003-09       Impact factor: 11.527

Review 9.  Myasthenia gravis and the thymus gland. A historical review.

Authors:  Marius Raica; Anca Maria Cimpean; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

Review 10.  Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.

Authors:  Electra Nicolaidou; Christina Antoniou; Alexander Stratigos; Andreas D Katsambas
Journal:  J Am Acad Dermatol       Date:  2009-01-20       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.